Search

Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.

… Friday, March 22, 2019 Summary Researchers have long pondered a possible link between drinking coffee and cancer risk. The evidence has been confusing and largely inconclusive. In recent years, intriguing research has suggested that drinking coffee might protect against colorectal cancer. A study published

Integrative medicine specialists determine which complementary therapies appear to be most effective.

… Thursday, May 18, 2017 Summary Though many people with cancer use complementary therapies, there is still some debate about which practices are truly effective. A new study suggests that mind-body therapies, such as meditation and yoga, have the best track record. Studies indicate that many people with

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.

… Monday, February 1, 2010 Summary In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States. People don’t usually think of math when

Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.

… Thursday, November 8, 2018 Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents, according to data we presented at the American Society of Clinical Oncology’s annual meeting

In this Q&A we discuss MSK’s pioneering work in rectal MRI, how it differs from endorectal ultrasound (ERUS), its role in groundbreaking clinical trials for patients with rectal cancer, why expertise matters, and new frontiers for future improvements to rectal MRI.

… Thursday, June 26, 2025 A Q&A with Dr. Marc J. Gollub, MSK’s Director of Gastrointestinal Radiology Memorial Sloan Kettering Cancer Center (MSK) has one of the busiest rectal cancer practices and likely performs the most rectal magnetic resonance imaging (MRI) exams in the United States. In this Q&A

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

… Thursday, April 3, 2008 A study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells. Metastasis is the cause of approximately 90 percent of all cancer-related deaths.

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.

… Tuesday, July 13, 2021 When it comes to body fat, what type you have and where it’s located is just as important as how much you have. Some people who are technically overweight are perfectly healthy because of where their fat is stored — subcutaneously (under the skin) rather than viscerally (around

Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth in this cohort.

… Friday, August 10, 2018 Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth compared

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

… Wednesday, December 21, 2011 As an enduring tribute to a valued Board member and woman of incomparable grace, Memorial Sloan Kettering Cancer Center has joined with The Robertson Foundation to undertake two high-profile initiatives in honor of Josephine “Josie” Robertson: the Josie Robertson Surgery

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

… Monday, April 1, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting